Prenatal tests for chromosomal abnormalities detection (PTCAD): pregnant women’s knowledge in an Italian Population

Background Nowadays several Prenatal Tests for Chromosomal Abnormalities Detection (PTCAD) are available. In those cases in which there is not an Institutional protocol to advise women about the available PTCAD, the choice of which one to undergo is up to the woman and largely depends on her knowled...

Full description

Saved in:
Bibliographic Details
Published in:Archives of gynecology and obstetrics 2021-05, Vol.303 (5), p.1185-1190
Main Authors: Quaresima, Paola, Visconti, Federica, Greco, Elena, Venturella, Roberta, Di Carlo, Costantino
Format: Article
Language:English
Subjects:
Amniocentesis
Diagnostic tests
Down syndrome
Education
Endocrinology
Gestational age
Gynecology
Human Genetics
Illiteracy
Informed consent
Knowledge
Legal medicine
Maternal-Fetal Medicine
Medicine
Medicine & Public Health
Miscarriage
Multiple choice
Obstetrics
Obstetrics/Perinatology/Midwifery
Population
Pregnancy
Questionnaires
Ultrasonic imaging
Womens health
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Nowadays several Prenatal Tests for Chromosomal Abnormalities Detection (PTCAD) are available. In those cases in which there is not an Institutional protocol to advise women about the available PTCAD, the choice of which one to undergo is up to the woman and largely depends on her knowledge about them. Therefore, we decided to evaluate, as a primary outcome, knowledge about PTCAD among pregnant women attending our Term Clinic. As a secondary outcome we evaluated the relationship between the patient’s knowledge and the subsequently chosen PTCAD. Methods From August 2017 to August 2018 an anonymous questionnaire with multiple-choice answers was administered to all pregnant women attending our Term antenatal Clinic, a tertiary obstetric unit in Catanzaro (Italy). Results Three hundred and twenty-five pregnant women were enrolled in the study. We observed that 28.8% of the pregnant women that chose one of the PTCAD, avoided the first trimester combined screening test; among these, 11.4% were in favour of the cell-free foetal DNA test. The latter was erroneously considered diagnostic by 34.3% of the women that had chosen it. Conclusions This study demonstrated that women’s knowledge about PTCAD is poor and that there is a potentially dangerous confusion between the words ‘screening’ and ‘diagnostic’. Informative campaigns about PTCAD and the application of dedicated antenatal counselling appointments should be a health-care priority to avoid unnecessary risks and costs for pregnant women and possible legal issues.
ISSN:0932-0067
1432-0711
DOI:10.1007/s00404-020-05846-2